These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Recurrent solitary fibrous tumour in the cerebellopontine angle. Bikmaz K, Cosar M, Kurtkaya-Yapicier O, Iplikcioglu AC, Gokduman CA. J Clin Neurosci; 2005 Sep; 12(7):829-32. PubMed ID: 16169731 [Abstract] [Full Text] [Related]
10. Solitary fibrous tumour of the tongue: a case report with immunohistochemical studies. Yamashita Y, Satoh T, Goto M. Int J Oral Maxillofac Surg; 2002 Dec; 31(6):681-3. PubMed ID: 12521330 [Abstract] [Full Text] [Related]
11. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S. Cancer; 2004 Sep 15; 101(6):1455-62. PubMed ID: 15316901 [Abstract] [Full Text] [Related]
17. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas. Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M. Cytometry B Clin Cytom; 2005 Mar 15; 64(1):43-52. PubMed ID: 15668953 [Abstract] [Full Text] [Related]
18. [Solitary fibrous tumor: the clinicopathologic and immunohistochemical characteristics of 26 cases]. Chen HJ, Zhang HY, Li X, Guo LX, Wei B, Guo H, Bu H, Yang K, Liu BL. Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep 15; 35(5):675-9. PubMed ID: 15460417 [Abstract] [Full Text] [Related]
19. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Tse GM, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, Putti TC. Am J Clin Pathol; 2002 Oct 15; 118(4):522-6. PubMed ID: 12375638 [Abstract] [Full Text] [Related]
20. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer. Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT. Acta Oncol; 2009 Oct 15; 48(4):522-31. PubMed ID: 19173092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]